Patents by Inventor Timothy Wright

Timothy Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240083997
    Abstract: This invention relates to methods employing IL-1 beta-ligand/IL-1 receptor disrupting compounds, such as IL-1 beta antibodies or IL-1 receptor antibodies, in the treatment and/or prevention of auto-inflammatory syndromes in mammals, particularly humans.
    Type: Application
    Filed: February 28, 2023
    Publication date: March 14, 2024
    Inventors: Hermann GRAM, Thomas JUNG, Philip LOWE, Trevor MUNDEL, Timothy WRIGHT
  • Publication number: 20240087738
    Abstract: A telepresence robot may include a drive system, a control system, an imaging system, and a mapping module. The mapping module may access a plan view map of an area and tags associated with the area. In various embodiments, each tag may include tag coordinates and tag information, which may include a tag annotation. A tag identification system may identify tags within a predetermined range of the current position and the control system may execute an action based on an identified tag whose tag information comprises a telepresence robot action modifier. The telepresence robot may rotate an upper portion independent from a lower portion. A remote terminal may allow an operator to control the telepresence robot using any combination of control methods, including by selecting a destination in a live video feed, by selecting a destination on a plan view map, or by using a joystick or other peripheral device.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 14, 2024
    Inventors: Yulun Wang, Charles S. Jordan, Tim Wright, Michael Chan, Marco Pinter, Kevin Hanrahan, Daniel Sanchez, James Ballantyne, Cody Herzog, Blair Whitney, Fuji Lai, Kelton Temby, Eben Christopher Rauhut, Justin H. Kearns, Cheuk Wah Wong, Timothy Sturtevant Farlow
  • Publication number: 20220133769
    Abstract: Provided herein are methods for the treatment of Alport syndrome, using a modified oligonucleotide targeted to miR-21. In certain embodiments, the modified oligonucleotide targeted to miR-21 improves kidney function and/or reduces fibrosis in subjects having Alport syndrome. In certain embodiments, administration of the modified oligonucleotide targeted to miR-21 delays the onset of end-stage renal disease in a subject having Alport syndrome. In certain embodiments, the modified oligonucleotide targeted to miR-21 delays the need for dialysis or kidney transplant in a subject having Alport syndrome.
    Type: Application
    Filed: September 14, 2021
    Publication date: May 5, 2022
    Applicant: SANOFI
    Inventor: Timothy Wright
  • Publication number: 20220098581
    Abstract: Provided herein are methods for oral administration of oligonucleotides. Further provided herein are methods for oral administration of modified oligonucleotides targeted to microRNA.
    Type: Application
    Filed: July 19, 2019
    Publication date: March 31, 2022
    Applicant: Regulus Therapeutics Inc.
    Inventor: Timothy Wright
  • Publication number: 20220079768
    Abstract: A prosthesis for the CMC joint of a thumb therefore includes a metacarpal component that has a first articular surface and a stem configured for insertion and anchoring into a metacarpal canal of a thumb metacarpal bone. The stem has a dorsal surface and an opposing volar surface. Each of the dorsal surface and the volar surface is defined by a proximal region and a distal region. The proximal region of the volar surface has a volar taper angle that is greater than distal region of the volar surface and a dorsal taper angle of proximal region of the dorsal surface is less than the volar taper angle of the proximal region of the volar surface. The prosthesis further includes a trapezial component having a second articular surface cooperating with the first articular surface. The trapezial component is configured to be coupled (e.g., anchored) to a trapezium bone.
    Type: Application
    Filed: September 15, 2021
    Publication date: March 17, 2022
    Inventors: Robert Hotchkiss, Aaron Daluiski, Timothy Wright, Fernando Quevedo-Gonzalez, Joseph Lipman, Daniel Osei, Darrick Lo, Ritvik Sarkar
  • Publication number: 20220073597
    Abstract: The present disclosure provides compositions, methods, kits, and platforms for selectively activating and deactivating chimeric receptor effector cells using humanized chimeric receptor effector cell switches that comprise a humanized targeting moiety that binds CD19 on a target cell and a chimeric receptor interacting domain that binds to a chimeric receptor effector cell and/or chimeric receptor effector cell switches comprising optimized chimeric receptor interacting domains. Also disclosed are methods of treating disease and conditions with such chimeric receptor effector cells and chimeric receptor effector cell switches.
    Type: Application
    Filed: August 30, 2021
    Publication date: March 10, 2022
    Inventors: Travis S. YOUNG, Leonard PRESTA, David RODGERS, Eric HAMPTON, Timothy WRIGHT, Peter G. SCHULTZ, Eduardo LABORDA, Elvira KHIALEEVA, Sophie VIAUD
  • Patent number: 11174306
    Abstract: The present disclosure provides compositions, methods, kits, and platforms for selectively activating and deactivating chimeric receptor effector cells using humanized chimeric receptor effector cell switches that comprise a humanized targeting moiety that binds CD19 on a target cell and a chimeric receptor interacting domain that binds to a chimeric receptor effector cell and/or chimeric receptor effector cell switches comprising optimized chimeric receptor interacting domains. Also disclosed are methods of treating disease and conditions with such chimeric receptor effector cells and chimeric receptor effector cell switches.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: November 16, 2021
    Assignee: The Scripps Research Institute
    Inventors: Travis S. Young, Leonard Presta, David Rodgers, Eric Hampton, Timothy Wright, Peter G. Schultz, Eduardo Laborda, Elvira Khialeeva, Sophie Viaud
  • Publication number: 20210309650
    Abstract: The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.
    Type: Application
    Filed: July 16, 2015
    Publication date: October 7, 2021
    Applicants: Merck Sharp & Dohme Corp., Merck Sharp & Dohme Ltd.
    Inventors: Carl A. Baxter, Edward Cleator, Faye Sheen, Shane W. Krska, Gavin Stewart, Neil Strotman, Debra J. Wallace, Timothy Wright
  • Publication number: 20210170034
    Abstract: Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity and comprise moieties that facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.
    Type: Application
    Filed: May 7, 2019
    Publication date: June 10, 2021
    Applicant: Regulus Therapeutics Inc.
    Inventors: Charles R. Allerson, Steven S. Neben, Timothy Wright
  • Publication number: 20210147533
    Abstract: This invention relates to methods employing IL-1 beta-ligand/IL-1 receptor disrupting compounds, such as IL-1 beta antibodies or IL-1 receptor antibodies, in the treatment and/or prevention of auto-inflammatory syndromes in mammals, particularly humans.
    Type: Application
    Filed: June 19, 2020
    Publication date: May 20, 2021
    Inventors: Philip LOWE, Hermann GRAM, Thomas JUNG, Timothy WRIGHT, Trevor MUNDEL
  • Publication number: 20210100828
    Abstract: Provided herein are methods for the treatment of Alport syndrome, using a modified oligonucleotide targeted to miR-21. In certain embodiments, the modified oligonucleotide targeted to miR-21 improves kidney function and/or reduces fibrosis in subjects having Alport syndrome. In certain embodiments, administration of the modified oligonucleotide targeted to miR-21 delays the onset of end-stage renal disease in a subject having Alport syndrome. In certain embodiments, the modified oligonucleotide targeted to miR-21 delays the need for dialysis or kidney transplant in a subject having Alport syndrome.
    Type: Application
    Filed: May 4, 2018
    Publication date: April 8, 2021
    Applicant: SANOFI
    Inventor: Timothy Wright
  • Patent number: 10769638
    Abstract: A method for validating payment information for an online transaction is provided. A payment server can receive two representations of the same payment information. The payment information can be validated if it is determined that the two representations match. If there is no match, or the payment information is otherwise invalid, the payment information can be repaired based on a trusted representation of the payment information, such as stored payment information or an image of an associated value token. Payment information can be received via one or more communication channels, and can be provided by one or more consumer devices. A merchant service provider can validate payment information and handle transaction processing on behalf of a merchant.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: September 8, 2020
    Assignee: VISA INTERNATIONAL SERVICE ASSOCIATION
    Inventors: Bharathi Ramavarjula, Nimesh Parikh, Timothy Wright
  • Patent number: 10677426
    Abstract: A luminaire mounting system can accommodate mounting a luminaire to different structures. The luminaire can comprise an adapter, which may be formed into or otherwise associated with a frame of the luminaire, for example. The adapter can provide a mechanical interface to different brackets that are configured for mounting to different structures. The adapter can connect to a first type of bracket that is configured for mounting to a vertically extending pole, to a second type of bracket that is configured for mounting to a horizontally extending pole, and to a third type of bracket that is configured for mounting to a wall or other flat surface.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: June 9, 2020
    Assignee: Eaton Intelligent Power Limited
    Inventor: Timothy Wright
  • Publication number: 20190359697
    Abstract: The present disclosure provides compositions, methods, kits, and platforms for selectively activating and deactivating chimeric receptor effector cells using humanized chimeric receptor effector cell switches that comprise a humanized targeting moiety that binds CD19 on a target cell and a chimeric receptor interacting domain that binds to a chimeric receptor effector cell and/or chimeric receptor effector cell switches comprising optimized chimeric receptor interacting domains. Also disclosed are methods of treating disease and conditions with such chimeric receptor effector cells and chimeric receptor effector cell switches.
    Type: Application
    Filed: October 19, 2017
    Publication date: November 28, 2019
    Inventors: Travis S. YOUNG, Leonard PRESTA, David RODGERS, Eric HAMPTON, Timothy WRIGHT, Peter G. SCHULTZ, Eduardo LABORDA, Elvira KHIALEEVA, Sophie VIAUD
  • Publication number: 20190154239
    Abstract: A luminaire mounting system can accommodate mounting a luminaire to different structures. The luminaire can comprise an adapter, which may be formed into or otherwise associated with a frame of the luminaire, for example. The adapter can provide a mechanical interface to different brackets that are configured for mounting to different structures. The adapter can connect to a first type of bracket that is configured for mounting to a vertically extending pole, to a second type of bracket that is configured for mounting to a horizontally extending pole, and to a third type of bracket that is configured for mounting to a wall or other flat surface.
    Type: Application
    Filed: January 28, 2019
    Publication date: May 23, 2019
    Inventor: Timothy Wright
  • Patent number: 10190752
    Abstract: A luminaire mounting system can accommodate mounting a luminaire to different structures. The luminaire can comprise an adapter, which may be formed into or otherwise associated with a frame of the luminaire, for example. The adapter can provide a mechanical interface to different brackets that are configured for mounting to different structures. The adapter can connect to a first type of bracket that is configured for mounting to a vertically extending pole, to a second type of bracket that is configured for mounting to a horizontally extending pole, and to a third type of bracket that is configured for mounting to a wall or other flat surface.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: January 29, 2019
    Assignee: COOPER TECHNOLOGIES COMPANY
    Inventor: Timothy Wright
  • Patent number: D840577
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: February 12, 2019
    Assignee: Eaton Intelligent Power Limited
    Inventors: Gregg Lehman, Timothy Wright
  • Patent number: D872343
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: January 7, 2020
    Assignee: Eaton Intelligent Power Limited
    Inventors: Gregg Lehman, Timothy Wright
  • Patent number: RE47859
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: February 18, 2020
    Assignee: Eaton Intelligent Power Limited
    Inventors: Christopher Ladewig, Timothy Wright
  • Patent number: D887077
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: June 9, 2020
    Assignee: Eaton Intelligent Power Limited
    Inventor: Timothy Wright